Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06212310 · ClinicalTrials.gov registry record
Genetic Counseling Service Delivery and Outcomes in Diverse and Underserved Populations
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 419
- Enrollment target
NCT06212310: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT06212310 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 419 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06212310 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 419 participants
- Enrollment target
Study Summary
This 2-arm prospective, randomized, controlled clinical trial compared outcomes of telephone genetic counseling (intervention) versus in-person genetic counseling (control) in an underserved, multilingual patient population referred for cancer genetic counseling at two North Texas safety-net hospitals. The main question\[s\] it aims to answer are: * Is telephone genetic counseling equal to in-person genetic counseling in the patient reported outcomes? Cancer genetics knowledge, attitude towards GT, and informed choice as well as GC-specific empowerment. * Is telephone genetic counseling-based clinical outcomes the same as in-person genetic counseling for visit completion and testing rates? Participants will be randomized to either in-person or telephone genetic counseling arm and complete standard of care genetic counseling visit process where testing is offered. Both arms will complete a series of surveys to assess the outcomes of interest.
Primary Outcome
Measure change in knowledge of basic principles of cancer genetics and implications of genetic testing for personal healthcare and relatives pre- and post- genetic counseling using the Multi-dimensional Model of Informed Choice (MMIC) scale knowledge score, with minimum and maximum scores of 0 and 8 respectively, and higher scores correlated with better knowledge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-12-31 |
What the finished NCT06212310 record still lists
NCT06212310 is an observational study that tracks outcomes without assigning an intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06212310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06212310 about?
NCT06212310 is a clinical study titled "Genetic Counseling Service Delivery and Outcomes in Diverse and Underserved Populations". This 2-arm prospective, randomized, controlled clinical trial compared outcomes of telephone genetic counseling (intervention) versus in-person genetic counseling (control) in an underserved, multilingual patient population referred for cancer genetic counseling at two North Texas safety-net hospita...
What is the current status of trial NCT06212310?
This trial is currently completed. The enrollment target is 419 participants. The study started on 2022-02-01. Estimated completion is 2023-12-31.
Who is sponsoring clinical trial NCT06212310?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI